SharePost Content Read More Yahoo Finance #finance Post navigation Summit Therapeutics (SMMT) Raises $500 Million Through Public Offering Here is Why Ultragenyx Pharmaceutical (RARE) is One of the Best Buy-the-Dip Stocks